Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1

Cancer

Volumn 79, Issue 7, 1997, Pages 1438-1446

  Maris, John M ^a   Wiersma, Susan R ^b   Mahgoub, Nidal ^c   Thompson, Patricia ^c   Geyer, Russell J ^d   Hurwitz, Carole G H ^e   Lange, Beverly J ^a   Shannon, Kevin M ^c,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chromosome; DNA; human; human chromosome 7 monosomy; leukemia; myelodysplastic syndromes; myeloid; neoplasm; neurofibromatosis 1; neurofibromatosis 1 gene; pair 7 monosomy; ras genes; second primary; suppressor; tumor

Indexed keywords

ANTINEOPLASTIC AGENT; RAS PROTEIN;

ARTICLE; CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; EMBRYONAL CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NEUROFIBROMATOSIS; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0030982905     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19970401)79:7<1438::aid-cncr22>3.0.co;2-%23     Document Type: Article

References (44)

1. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr 1978;92:925-9.
2. Riccardi VM, Eichner JE. Neurofibromatosis. Baltimore: Johns Hopkins University Press, 1986.
3. Schneider M, Obringer AC, Zackai E, Meadows AT. Childhood neurofibromatosis: risk factors for malignant disease. Cancer Genet Cytogenet 1986;21:347-54.
4. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010-5.
5. Shearer P, Parham D, Kovnar E, Kun L, Rao B, Lobe T, et al. Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 1994;22:78-83.
6. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746-54.
7. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:597-601.
8. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, et al. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. Blood 1992;79:1311-8.
9. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
10. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-6.
11. Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
12. Xu G, O'Connell P, Viskochil D, Cawthron R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
13. Skuse GR, Kosciolek BA, Rowley PT. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosom Cancer 1989;1:36-41.
14. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 1990;87:5435-9.
15. Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosom Cancer 1991;3:62-70.
16. Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG, et al. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosom Cancer 1992;4:337-42.
17. Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993;3:122-6.
18. LeBeau M, Albain KS, Larson RA, Vardiman J, Davis E, Blough R, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes 5 and 7. J Clin Oncol 1986;3:325-45.
19. Rowley JD, Golomb HM, Vardiman JW. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981;58:759-68.
20. Orazi A, Cattoretti G, Soligo D, Luksch R, Lambertenghi-Deliliers G. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. Leukemia 1993;7:838-847.
21. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: abnormalities of chromosome 5 and 7 are common. Blood 1991;78:2982-7.
22. Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications [review]. Blood 1995;85:1985-99.
23. Perilongo G, Felix CA, Meadows AT, Nowell P, Biegel J, Lange BJ. Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report. Leukemia 1993;7:912-5.
24. NIH Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:575-8.
25. Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1994;12:2126-31.
26. Sposto R, Ertel IJ, Jenkin RDT, Boesel CP, Venes JL, Ortega JA, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neurooncol 1989;7:165-77.
27. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VE, Finkelstein JZ, et al. Intensive therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: early conclusions of CCG 106 by the Children's Cancer Study Group. Lancet 1988;2(8617):921-4.
28. Shannon KM, Turhan AG, Chang SSY, Bowcock AM, Rogers PCJ, Carroll WL, et al. Familial bone marrow monosomy 7: evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 1989;84:984-9.
29. Xu G, Nelson L, O'Connell P, White R. An Alu polymorphism intragenic to the neurofibromatosis type 1 gene. Nucleic Acids Res 1991;19:3764.
30. Andersen LB, Tarle SA, Marchuk DA, Legius E, Collins FS. A highly informative compound nucleotide repeat in the neurofibromatosis (NF1) gene. Hum Mol Genet 1993; 2:1083-6.
31. Jensen S, Paderanga D, Chen P, Olson K, Edwards M, Iavorone A, et al. Molecular analysis at the NF1 locus in astrocytic brain tumors. Cancer 1995;76:674-7.
32. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990;5:1037-43.
33. Kalra R, Paderanga DC, Olson K, Shannon KM. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 1994;84:3435-9.
34. Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, et al. Malignant transformation in patients with congenital neutropenia during treatment with recombinant granulocyte colony stimulating factor. Blood 1995;86:4579-86.
35. Miles DK, Freedman MH, Stephens K, Pallavicinin M, Sievers E, Leppig K, et al. Allelic loss at the NF1 locus and hematopoietic lineage involvement in malignant bone marrows from children with neurofibromatosis type 1. Blood 1995; 86:51a.
36. Jacks T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nat Genet 1994; 7:353-61.
37. Lubbert M, Mirro J, Kitchingman G, McCormick F, Mertelesmann R, Herrmann F, et al. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 1992;7:263-8.
38. Neubauer A, Shannon K, Liu E. Mutations of the ras protooncogenes in childhood monosomy 7. Blood 1991;77:594-8.
39. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 1994;83:2248-54.
40. Bollag G, Clapp DW, Shih S, Adler F, Zhang Y, Thompson P, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat Genet 1996;12:144-8.
41. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG. Nf1 deficiency causes Ras-mediated granulocyte-macrophage colony stimulating factor hypersensitivity and chronic myeloid leuekemia. Nat Genet 1996;12:137-43.
42. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986; 53:661-71.
43. Upadhyaya M, Shaw D, Harper P. Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 1994;4:83-101.
44. Heim R, Kam-Morgan L, Binnie C, Corns D, Cayouette M, Farber R, et al. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 1995;4:975-81.